Literature DB >> 19573772

Do high-volume hospitals and surgeons provide better care in urologic oncology?

James A Eastham1.   

Abstract

Studies focusing primarily on hospital or surgical volume as a surrogate for surgical experience have found substantial variations in outcomes. Increasing surgical experience has been shown to improve outcomes after multiple procedures, including esophagectomy, pancreatectomy, and primary surgery for colon and breast cancer. More recently, evidence has been presented that surgical volume/experience affects quality of life and cancer control outcomes after urologic oncology procedures. Although most of these data pertain to radical prostatectomy, similar conclusions have been reached for radical cystectomy, retroperitoneal lymph node dissection, and management of renal cell carcinoma. This review highlights data indicating that high-volume surgeons and hospitals provide better care for radical prostatectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19573772     DOI: 10.1016/j.urolonc.2009.01.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  14 in total

1.  Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Authors:  Sigrid Carlsson; Andrew J Vickers; Monique Roobol; James Eastham; Peter Scardino; Hans Lilja; Jonas Hugosson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

Review 2.  A systematic review of the volume-outcome relationship for radical prostatectomy.

Authors:  Quoc-Dien Trinh; Anders Bjartell; Stephen J Freedland; Brent K Hollenbeck; Jim C Hu; Shahrokh F Shariat; Maxine Sun; Andrew J Vickers
Journal:  Eur Urol       Date:  2013-04-19       Impact factor: 20.096

3.  Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care.

Authors:  Karyn B Stitzenberg; Yu-Ning Wong; Matthew E Nielsen; Brian L Egleston; Robert G Uzzo
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

4.  Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study.

Authors:  Michael P Porter; John L Gore; Jonathan L Wright
Journal:  World J Urol       Date:  2010-12-05       Impact factor: 4.226

Review 5.  Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

Authors:  Andrew H Feifer; Jennifer M Taylor; Tatum V Tarin; Harry W Herr
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

6.  Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.

Authors:  Murilo A Luz; Ahmed F Kotb; Saad Aldousari; Fadi Brimo; Simon Tanguay; Wassim Kassouf; Armen G Aprikian
Journal:  World J Surg Oncol       Date:  2010-11-09       Impact factor: 2.754

7.  Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer.

Authors:  Eva H DuGoff; Justin E Bekelman; Elizabeth A Stuart; Katrina Armstrong; Craig Evan Pollack
Journal:  Health Serv Res       Date:  2014-01-24       Impact factor: 3.402

8.  Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Authors:  Sigrid V Carlsson; Tiago M de Carvalho; Monique J Roobol; Jonas Hugosson; Anssi Auvinen; Maciej Kwiatkowski; Arnauld Villers; Marco Zappa; Vera Nelen; Alvaro Páez; James A Eastham; Hans Lilja; Harry J de Koning; Andrew J Vickers; Eveline A M Heijnsdijk
Journal:  Cancer       Date:  2016-07-26       Impact factor: 6.860

Review 9.  Is there an optimal management for localized prostate cancer?

Authors:  Jaspreet Singh; Edouard J Trabulsi; Leonard G Gomella
Journal:  Clin Interv Aging       Date:  2010-08-09       Impact factor: 4.458

10.  Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma.

Authors:  Shouki Bazarbashi; Sultan Alkhateeb; Ashraf Abusamra; Danny Rabah; Mohammed Alotaibi; Mubarak Almansour; Esam Murshid; Abdullah Alsharm; Ashwaq Alolayan; Imran Ahmad; Khalid Alghamdi; Abdullah Alghamdi
Journal:  Urol Ann       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.